Navigation Links
Macrophage proliferation appears to drive progression of atherosclerosis
Date:8/11/2013

New insights into the development of vulnerable atherosclerotic plaques could lead to better treatment or prevention of heart attacks and strokes. In a report being published online in Nature Medicine, researchers at the Massachusetts General Hospital (MGH) Center for Systems Biology re-evaluated previous assumptions regarding the role of inflammatory cells in atherosclerosis and found that the process relies on proliferation of certain immune cells within plaques and not exclusively on the uptake of cells from the blood.

The prevailing theory of atherosclerosis has been that plaques grow by drawing white blood cells called monocytes in from the circulation. These monocytes then mature into macrophages, cells that ingest lipid and cholesterol molecules but remain within the plaques, leading to the buildup of a fatty core that contributes to the risk of plaque rupture. While it had been believed that each macrophage descended from a single monocyte that had entered a plaque, the MGH team found that proliferation of new macrophages within plaques is a major driver of their growth.

"Currently, there is quite a bit of interest in targeting inflammation as a way to treat vascular disease, and one of the ways to do so is by targeting the cells responsible, says Filip Swirski, PhD, of the MGH Center for Systems Biology, senior author of the Nature Medicine report. "We discovered that the atherosclerotic lesion is a very dynamic environment, and even though the macrophages within a lesion are fundamentally derived from monocytes, they do not require constant monocyte input to sustain their numbers."

In a series of experiments in mice, the MGH-CSB team first found that existing plaques within the aortas of animals fed a high-cholesterol diet showed evidence of a rapid and constant proliferation of macrophages that did not require the presence of monocytes in the blood. Although monocytes were needed for the initiation of atherosclerosis, once plaques had formed, macrophage proliferation became the primary mechanism for the further growth of plaques. The investigators also identified a receptor protein on macrophages that appears to contribute to their proliferation within plaques without the involvement of monocytes. While further study is required to determine whether the same processes occur in humans, the MGH team did find evidence of macrophage proliferation in plaques from human carotid arteries.

"I think this work will force some major re-evaluations," says Swirski, an assistant professor of Radiology at Harvard Medical School. "People have been thinking of targeting monocyte influx to treat atherosclerosis, but they need to consider macrophage proliferation as an additional or alternative approach, especially in established disease. That might actually be better than targeting circulating monocytes, since interrupting pathological processes within the plaques themselves could spare the beneficial immune responses mediated by monocytes."


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Related medicine news :

1. CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
2. TG02 Potently Inhibits the Proliferation and Survival of Multiple Myeloma Cell Lines through Depletion of the Key Survival Protein MCL-1
3. Soy-based compound may reduce tumor cell proliferation in colorectal cancer
4. Off-Label Drug Use Appears Common
5. Exercise Appears to Ease Nerve-Damage Pain in Rat Study
6. New Pill Appears Effective, Safe for Ulcerative Colitis: Study
7. New Drug Appears to Extend Survival in Advanced Prostate Cancer Patients
8. Ancient Genome Appears to Have Links to Modern Humans
9. Decline in incidence of heart attacks appears associated with smoke-free workplace laws
10. Meditation appears to produce enduring changes in emotional processing in the brain
11. Experimental Antidepressant Appears Quick-Acting, Safe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... asset protection and financial planning services to families and business owners in the ... aimed at supporting children with developmental disabilities. , The Lakemary Center is a ...
(Date:1/18/2017)... Staefa, Switzerland (PRWEB) , ... January 18, 2017 ... ... will for the first time support an aid project with the donation of ... will get the gift of hearing and thus a fair chance of leading ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Anesthesia Progress ... for dentists to choose the best drug option for each patient. Dentists have several ... and better overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance ... The company, owned and operated by Ed Stroup, was created to offer the ... the highest level of customer service. Healthful Balance products can be purchased online ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... as Palm Desert, is opening a new office in San Clemente, California this ... stimulation (dTMS) in Southern California, successfully treating individuals struggling with major depression. Depression ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
(Date:1/18/2017)... 2017 Ximbio, a non-profit online one-stop-shop ... has opened its first North American headquarters in Kendall Square, ... ... Ximbio following its launch in October 2014 as a business ... commercialization arm of the foundation Cancer Research UK. ...
(Date:1/18/2017)... Regulatory Authority Chinese Food and Drug Administration CSL ... Flanders Institute Food and Drug Administration FORT ... Glaxo Smith Klein GlaxoWellcome Global ... Japan Immune Targeting Systems Indian Association ... oxford Johnson & Johnson Krka Pharmaceuticals ...
Breaking Medicine Technology: